Ignacio Puche Sanz-rekin lankidetzan egindako argitalpenak (8)

2022

  1. Genetic variants of antioxidant enzymes and environmental exposures as molecular biomarkers associated with the risk and aggressiveness of bladder cancer

    Science of the Total Environment, Vol. 843

2021

  1. Role of IGF2 in the Study of Development and Evolution of Prostate Cancer

    Frontiers in Genetics, Vol. 12

2020

  1. Liquid biopsy and prostate cancer. Current evidence applied to clinical practice

    Actas Urologicas Espanolas, Vol. 44, Núm. 3, pp. 139-147

2019

  1. GSTM1 gene expression and copy number variation in prostate cancer patients—Effect of chemical exposures and physical activity

    Urologic Oncology: Seminars and Original Investigations, Vol. 37, Núm. 4, pp. 290.e9-290.e15

  2. The role of miRNAs as biomarkers in prostate cancer

    Mutation Research - Reviews in Mutation Research, Vol. 781, pp. 165-174

2017

  1. A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: Biological and clinical implications of EGFR, AR and SNPs

    Oncotarget, Vol. 8, Núm. 41, pp. 70472-70482

  2. Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness

    PLoS ONE, Vol. 12, Núm. 10

2016

  1. Dormant circulating tumor cells in prostate cancer: Therapeutic, clinical and biological implications

    Current Drug Targets, Vol. 17, Núm. 6, pp. 693-701